Chloe Ramirez
Hepatitis A is a serious and potentially fatal disease of the liver that is caused by the hepatitis A virus (HAV). It is most often spread through infected food or water, or by close person-to-person contact. The hepatitis A vaccine is highly effective in preventing HAV infection by stimulating the body's production of antibodies to the virus. The vaccine is given as two shots over six months and is recommended for children from 12 months old, with a booster vaccination after another six to twelve months. The most common side effects are mild and include fever, headache, tiredness, soreness, and redness at the injection site. The vaccine is known by several trade names, including Havrix, VAQTA, and Twinrix.
| Characteristics | Values |
|---|---|
| Proper Name | Hepatitis A Vaccine |
| Tradename | HAVRIX, VAQTA, Twinrix |
| Manufacturer | GlaxoSmithKline Biologicals |
| Age Indication | 12 months and older |
| Administration | Two shots over 6 months |
| Effectiveness | Highly effective in preventing HAV infection |
| Side Effects | Fever, injection site reactions, rash, headache, tiredness, loss of appetite, soreness, redness |
| Allergic Reaction | Rare |
Explore related products
What You'll Learn
Hepatitis A vaccine brand names: Havrix, VAQTA, Twinrix
Hepatitis A vaccines are available under the brand names Havrix, VAQTA, and Twinrix. These vaccines are designed to provide active immunization against the hepatitis A virus (HAV) in individuals aged 12 months and older.
Havrix, manufactured by GlaxoSmithKline Biologicals, is approved for use in individuals aged 12 months and older. It offers protection against the disease caused by the hepatitis A virus.
VAQTA, also known as the Hepatitis A Vaccine, Inactivated, is indicated for the prevention of hepatitis A in individuals aged 12 months and older. It can be administered concomitantly with other vaccines, such as typhoid Vi polysaccharide and yellow fever vaccines in adults, and measles, mumps, and rubella vaccines in children. However, it should not be given to individuals with a history of severe allergic reactions to any component of the vaccine, including neomycin.
Twinrix is a combination vaccine that provides protection against both hepatitis A and hepatitis B. The standard dosing schedule for Twinrix consists of three vaccine doses administered over a span of 6 months, with the second dose coming 1 month after the first and the last dose coming 6 months after the initial dose. A 4-dose rapid schedule is also available for adults aged 19 years and older.
It is important to consult with healthcare professionals to determine the appropriate vaccination schedule and brand for Hepatitis A immunization, as they can provide personalized advice and guidance based on individual needs and travel plans.
Modified Toxins: How Vaccines Fight Bacteria
You may want to see also
Explore related products
Hepatitis A vaccine side effects: fever, soreness, allergic reaction
Hepatitis A is a serious and potentially fatal liver disease caused by the hepatitis A virus (HAV). The hepatitis A vaccine is highly effective in preventing HAV infection. It works by causing the body to produce its own antibodies against the disease. The vaccine is quite safe and is approved for use in persons 12 months of age and older.
Like any medicine, there is a very remote chance of the hepatitis A vaccine causing a severe allergic reaction, other serious injury, or death. This is, however, a very rare occurrence. Signs of a serious allergic reaction include dizziness, vision changes, or ringing in the ears. If you believe you are having an allergic reaction to the vaccine, you should call your healthcare provider right away.
The most frequently reported adverse events associated with the hepatitis A vaccine are fever, soreness at the injection site, and rash. Other potential side effects include mild headache, nausea, fatigue, malaise, and loss of appetite. These side effects are typically mild and usually last 1-2 days. Fainting may also occur after receiving the vaccine.
It is important to note that certain people should consult a healthcare professional before receiving the hepatitis A vaccine, such as those who have previously experienced an allergic reaction to any component of the vaccine, including neomycin or yeast. Additionally, individuals with other types of allergies, such as to foods, dyes, preservatives, or animals, should disclose this information to their healthcare provider.
Pneumonia Vaccine: How Often for Protection?
You may want to see also
Explore related products
Hepatitis A vaccine efficacy: highly effective, long-term immunity
Hepatitis A is a serious and potentially deadly liver disease caused by the hepatitis A virus (HAV). The disease spreads most often through infected food or water and close person-to-person contact. Hepatitis A vaccines are highly effective in preventing HAV infection and are generally safe for both children and adults. The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for children aged 12-23 months and catch-up vaccination for children aged 2-18 years. Vaccination is also recommended for unvaccinated adults at increased risk of infection or severe disease.
There are two brands of hepatitis A vaccine available in the United States: Havrix and Vaqta. Both vaccines are administered as two shots over six months, with the second dose of Havrix given 6-12 months after the first and the second dose of Vaqta given 6-18 months after the initial dose. Completing the full vaccination schedule offers long-term protection against HAV infection. According to studies, anti-HAV antibodies have been shown to persist for at least 20 years in people who received the complete vaccine series, and the vaccine may even offer lifetime protection. Immunize.org suggests that the vaccine might last at least 25 years for adults and 14-20 years for children.
The most commonly reported side effects of the hepatitis A vaccine include soreness, tiredness, headache, and fever, which typically resolve within a few days. Serious side effects are rare. Before administering the vaccine, clinicians should ask patients if they have previously experienced an allergic reaction to any component of the vaccine or to neomycin or yeast, which are contraindications for the combination hepatitis A and B vaccine known as Twinrix.
Antibodies: What They Don't Do and Why
You may want to see also
Explore related products
Hepatitis A vaccine dosage: two shots over 6 months
Hepatitis A is a serious and potentially fatal liver disease caused by the hepatitis A virus (HAV). The virus is spread most often through infected food or water, as well as close person-to-person contact. Hepatitis A vaccines are highly effective in preventing HAV infection. The immunoglobulin G (IgG) anti-HAV produced after vaccination confers long-term immunity.
Hepatitis A vaccines are typically administered in two doses, with the second dose given six months after the first. The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for children aged 12-23 months and catch-up vaccination for children aged 2-18 years who have not previously received the vaccine. The minimum time between both doses is six months. The vaccine is given as two shots over six months for both children and adults.
The hepatitis A vaccine may be administered concurrently with other vaccines, and there is no evidence that this reduces the vaccine's response or effectiveness. The vaccine is generally safe for infants and is effective at protecting against HAV infection and serious illness. However, appropriate studies have not been performed on the relationship of age to the effects of the hepatitis A vaccine in children younger than 12 months of age. Safety and efficacy have not been established for this age group.
The most frequently reported adverse events associated with the hepatitis A vaccination are fever, injection site reactions, and rash. Fainting may also occur after receiving the vaccine. Although the hepatitis A vaccine is safe, it may not protect everyone who receives it. It is important to take precautions to reduce the risk of HAV infection, even after vaccination.
Vaccine Route and Site: What's the Right Combo?
You may want to see also
Hepatitis A vaccine administration: intramuscular injection
Hepatitis A vaccines are highly effective in preventing infection by the hepatitis A virus (HAV). The vaccines work by causing the body to produce its own antibodies against the disease. Hepatitis A is a serious, and potentially fatal, liver disease that is spread through infected food or water, or close person-to-person contact. It is less common in areas with good sanitation and waste systems, but it is a significant health problem in parts of the world that do not have these systems in place.
The hepatitis A vaccine is administered intramuscularly via injection into the anterolateral aspect of the thigh or the deltoid muscle of the upper arm, depending on the patient's age. The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for children aged 12-23 months, and catch-up vaccination for children aged 2-18 years who have not previously received the vaccine. Unvaccinated adults at increased risk of infection should also be vaccinated. Hepatitis A vaccines are administered as a series of two shots over 6 months for single-dose vaccines, and three shots over 6 months for combination vaccines.
The most frequently reported adverse events associated with the hepatitis A vaccine are fever, injection site reactions, and rash. Fainting may also occur. Any adverse events suspected to be associated with the vaccine should be reported through the Vaccine Adverse Event Reporting System (VAERS). Patients should inform their doctor if they have any other medical problems, especially allergies to neomycin, bleeding problems such as haemophilia, or a weak immune system.
The two single-antigen hepatitis A vaccines licensed by the FDA are Havrix and Vaqta, and the licensed combination vaccine for hepatitis A and B is Twinrix. All three are inactivated vaccines containing an aluminium adjuvant.
The Mystery of Round-Scar Vaccines
You may want to see also
Frequently asked questions
The hepatitis A vaccine is known by several trade names, including Havrix, VAQTA and Twinrix.
The hepatitis A vaccine contains a small piece of the hepatitis A virus that has been killed or inactivated. This helps your body learn to attack the virus if you are exposed to it.
The hepatitis A vaccine is given as an injection or shot in the arm. For children, it is administered into the anterolateral aspect of the thigh or the deltoid muscle of the upper arm.
The hepatitis A vaccine is recommended for children aged 12-23 months old, with a second dose at least six months later. Babies as young as six months can get the vaccine if they will travel to a place where hepatitis A infections are common. The vaccine is also recommended for people who work with the hepatitis A virus in a laboratory or with primates that may be infected.
The most common side effect of the hepatitis A vaccine is pain at the injection site. Other mild side effects include low fever, headache, tiredness, loss of appetite, and soreness or redness where the shot was given. These side effects typically go away after a couple of days.
